Omeros (OMER) EBITDA Margin Growth (5y) (2015 - 2026)
Omeros (OMER) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,895.00 |
| Jun 30, 2022 | -30,099.00 |
| Mar 31, 2022 | -39,713.00 |
| Dec 31, 2021 | 14,557.00 |
| Sep 30, 2021 | -2,611.00 |
| Jun 30, 2021 | -4,900.00 |
| Mar 31, 2021 | 4,715.00 |
| Dec 31, 2020 | -4,780.00 |
| Sep 30, 2020 | 49,486.00 |
| Jun 30, 2020 | 29,642.00 |
| Mar 31, 2020 | 452,054.00 |
| Dec 31, 2019 | 1.10 Mn |
| Sep 30, 2019 | 796,843.00 |
| Jun 30, 2019 | 3.82 Mn |
| Mar 31, 2019 | 1.56 Mn |
| Dec 31, 2018 | 814,213.00 |
| Sep 30, 2018 | 608,494.00 |
| Jun 30, 2018 | 755,003.00 |
| Mar 31, 2018 | -82,857.00 |
| Dec 31, 2017 | 37,325.00 |